Commentary: Can replacement therapy work in the treatment of cocaine dependence? and what are we replacing anyway?

Addiction

Volumn 102, Issue 12, 2007, Pages 1888-1889

  Vocci, Frank J ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BUPRENORPHINE; CARBIDOPA PLUS LEVODOPA; COCAINE; DEXAMPHETAMINE; DOPAMINE; METHYLPHENIDATE; MODAFINIL; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG EFFICACY; HUMAN; NOTE; SUBSTITUTION THERAPY; SYMPTOMATOLOGY; TREATMENT RESPONSE; METABOLISM;

CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE-RELATED DISORDERS; DOPAMINE; HUMANS;

EID: 36348941661     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.02014.x     Document Type: Note

References (11)

1. Castells X., Casas M., Vidal X., Bosch R., Roncero C., Ramos-Quiroga J. A. et al. Efficacy of CNS stimulant treatment for cocaine dependence. A systematic review and meta-analysis of randomized controlled clinical trials. Addiction 2007 102 : 1871 87.
2. Vocci F., Ling W. Medications development: successes and challenges. Pharmacol Ther 2005 108 : 94 108.
3. Staley J. K., Mash D. C. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996 16 : 6100 6.
4. Levin F. R., Evans S. M., Brooks D. J., Garawi F. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 2007 87 : 20 9.
5. Volkow N., Fowler J. S., Wang G. J., Hitzemann R., Logan J., Schlyer D. J. et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993 14 : 169 77.
6. Volkow N., Wang G. J., Fowler J. S., Logan J., Gatley S. J., Hitzemann R. et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997 386 : 830 3.
7. Little K., Krowleski D. M., Zhang L., Cassin B. J. Loss of vesicular monoamine transporter protein (VMAT2) in human cocaine users. Am J Psychiatry 2003 160 : 47 55.
8. Leyton M., aan het Rot M., Booij L., Baker G. B., Young S. N., Benkelfat C. Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. J Psychiatry Neurosci 2007 32 : 129 36.
9. Mooney M. E., Schmitz J. M., Moeller F. G., Grabowski J. Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials. Drug Alcohol Depend 2007 88 : 214 33.
10. Breiter H. C., Aharon I., Kahneman D., Dale A., Shizgal P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 2001 30 : 619 39.
11. Knutson B., Taylor J., Kaufman M., Peterson R., Glover G. Distributed neural representation of expected value. J Neurosci 2005 25 : 4806 12.